- Grants since 2016
- 586
- Awarded, last 5 years (where amounts are published)
- CAD 165.4M
- Funded works, last 5 years
- 578
- Funded works, all time
- 2 936
Grants
2020–2022 · research · Innovation Grants
Unexpected expression of PD1 on brain tumour initiating cells: a novel regulator of glioblastoma growth
V. Wee Yong · University of Calgary
2020–2022 · research · Innovation Grants
Oncolytic virus therapy for U1 mutant cancers
Lincoln Stein · Ontario Institute for Cancer Research
2020–2022 · research · Innovation Grants
Characterizing DCIS heterogeneity and disease progression
Luke Mccaffrey · McGill University
2020–2022 · research · Innovation Grants
Investigating the role of signal 4 on inflammatory monocytes in tissue resident memory T cell formation and control of melanoma during STING agonist therapy
Tania Watts · University of Toronto
2020–2023 · research · innovation to impact grants
Capitalizing on an oxidative stress response to sensitize poor outcome cancers to PARP inhibitors.
Josie Ursini Siegel · Jewish General Hospital
2020–2022 · research · Innovation Grants
Small molecule inhibitors of O GlcNAc transferase: validation of a new anticancer target
Robert Britton · Simon Fraser University
2020–2022 · research · Innovation Grants
Proteogenomics of meningiomas to facilitate molecular classification and identify novel therapeutic options
Gelareh Zadeh · The Toronto Hospital (western Division) Uhn
2020–2023 · research · Innovation Grants (co-funded with CIHR-IMHA)
An automated algorithm to identify and characterize skin cancers from population based pathology reports
Frances Wright · Ontario Health
2020–2022 · research · Innovation Grants
Use of oncolytic viruses to overcome immune checkpoint inhibitor resistance in melanoma
Ian Watson · McGill University
2020–2022 · research · Prostate Cancer Implementation Research Grants
Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function: Implementing a Prehabilitation Intervention for Radical Prostatectomy
Lin Yang · University of Calgary
2020–2023 · research · innovation to impact grants
Bioengineering peak transgene production during viral oncolysis
Tommy Alain · Children's Hospital of Eastern Ontario
2020–2022 · research · Prostate Cancer Implementation Research Grants
Community preferences for prostate cancer outcomes: measuring community preference weights for the Patient-Oriented Prostate Utility Scale (PORPUS)
Murray Krahn · University Health Network
2020–2023 · research · innovation to impact grants
Clinical application of a targeted proteomic classifier for triple negative breast cancer
Gregg Morin · Provincial Health Services Authority
2020–2023 · research · Innovation Grants
Characterizing molecular mediators of leptomeningeal metastasis
Peter Siegel · McGill University
2020–2022 · research · Innovation Grants
Enhancing oncolytic virus efficacy using effector peptides
Jean Simon Diallo · Ottawa Hospital Research Institute
2020–2022 · research · Innovation Grants
Using nanopore technology to develop rapid, real time, clinical molecular oncology testing
Rola Saleeb · St. Michael's Hospital
2020–2022 · research · Innovation Grants
Sublethal apoptosis as a driver of breast cancer recurrence
Ing Swie Goping · University of Alberta
2020–2022 · research · Innovation Grants
Radiation nanomedicine combined with checkpoint immunotherapy for treatment of glioblastoma multiiforme (GBM)
Raymond Reilly · University of Toronto
2020–2022 · research · Innovation Grants
Pilot study of the rectal cancer checklist and a reminder system to improve pre operative surgeon evaluation of surgical margins among patients with rectal cancer
Marko Simunovic · McMaster University
2020–2022 · research · Innovation Grants
Aldehydes as an imaging biomarker for lung cancer detection and staging by PET
Adam Shuhendler · University of Ottawa
2020–2022 · research · Prostate Cancer Implementation Research Grants
Prostate MRI in Biopsy-Naive Patients: Implementation in a Publicly Funded Health Care System
Antonio Finelli · University Health Network
2020–2023 · research · innovation to impact grants
Combined 4FMFES and FDG PET imaging in advanced breast cancer: a phase II study
Eric Turcotte · Université de Sherbrooke
2020–2022 · research · Innovation Grants
Identifying pathways for cancer care from family physicians' electronic medical records
Liisa Jaakkimainen · Institute for Clinical Evaluative Sciences
2020–2022 · research · Innovation Grants
2B or not 2B: that is the question about KRAS function.
Antonis Koromilas · Jewish General Hospital
2020–2022 · research · Innovation Grants
Developing therapeutic approaches to treat poor outcome metaplastic breast carcinomas
Morag Park · McGill University
2020–2022 · research · Innovation Grants
Clonal stromapoiesis and BM microenvironment in leukemias and HCT
Dennis Kim · Princess Margaret Cancer Centre Uhn
2020–2022 · research · Innovation Grants
Mechanism of resistance to anti PD 1/L1 immunotherapy and strategies to overcome resistance
Shawn Li · Western University
2020–2026 · research · Movember Prostate Cancer Translation Acceleration Grant in Advanced Imaging
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer (PATRON): A Pragmatic Phase III Randomized Controlled Trial
Cynthia Menard · Centre Hospitalier de l’Université de Montréal
2020–2022 · research · Innovation Grants
Modelling brain metastasis
Liliana Attisano · University of Toronto
2020–2022 · research · Innovation Grants
Targeting a novel pyruvate metabolic cycle to restore the senescent tumour suppression mechanism in tumours
Gerardo Ferbeyre · Université de Montréal
2020–2022 · research · Innovation Grants
MRCK inhibitor optimization for glioblastoma therapy
Michael Olson · Toronto Metropolitan University
2019–2021 · research · Innovation Grants
Amplification and Enrichment Platforms for Liquid Biopsy based Early Prognostication of Cancer
Roger Zemp · University of Alberta
2019–2021 · research · Innovation Grants
Toward improved immunotherapy for ovarian cancer: quantifying the diversity, phenotype and temporal dynamics of tumour reactive T cells from primary treatment to relapse
Mark Brockman · Simon Fraser University
2019–2021 · research · Innovation Grants
Breathomics as a non invasive, inexpensive, point of care predictive test for immune checkpoint inhibitor efficacy
Geoffrey Liu · Princess Margaret Cancer Centre Uhn
2019–2021 · research · Innovation Grants
Exploiting an actionable metabolic vulnerability in high risk myeloma
Linda Penn · Princess Margaret Cancer Centre Uhn
2019–2021 · research · Innovation Grants
Offering nicotine patches to all households in a municipality with high smoking rates: Test of an innovative idea to promote large increases in tobacco cessation
John Cunningham · Centre for Addiction and Mental Health
2019–2024 · research · CCS/CIHR Cancer Survivorship Team Grants, in partnership with ACF (in partnership with the Alberta Cancer Foundation)
Preparing to survive: Improving outcomes for young women with breast cancer
May Lynn Quan · University of Calgary
2019–2022 · research · Innovation to Impact Grants
Developing an anti fibrosis treatment to improve cancer survivorship
Fei Fei Liu · Princess Margaret Cancer Centre Uhn
2019–2022 · research · Innovation to Impact Grants
Incorporating advanced capabilities in best in class PEM system for improved clinical outcomes
Alla Reznik · Lakehead University
2019–2024 · research · Impact Grants
Setting a trap for cancer cells: high throughput screening for protein trapping synthetic lethal targets for cancer therapy
Philip Hieter · University of British Columbia
